UBS Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-72,662
| Closed | -$13.1K | – | 9919 |
|
|
2022
Q4 | $13.1K | Buy |
72,662
+60,676
| +506% | +$10.9K | ﹤0.01% | 7014 |
|
|
2022
Q3 | $5K | Buy |
+11,986
| New | +$5K | ﹤0.01% | 8182 |
|
|
2022
Q2 | – | Sell |
-522
| Closed | -$3K | – | 10197 |
|
|
2022
Q1 | $3K | Sell |
522
-105,682
| -100% | -$607K | ﹤0.01% | 8499 |
|
|
2021
Q4 | $1.03M | Buy |
106,204
+24,734
| +30% | +$239K | ﹤0.01% | 3430 |
|
|
2021
Q3 | $1.46M | Buy |
81,470
+71,837
| +746% | +$1.28M | ﹤0.01% | 2977 |
|
|
2021
Q2 | $235K | Sell |
9,633
-1,478
| -13% | -$36.1K | ﹤0.01% | 4227 |
|
|
2021
Q1 | $294K | Buy |
11,111
+8,231
| +286% | +$218K | ﹤0.01% | 4256 |
|
|
2020
Q4 | $22K | Buy |
2,880
+1,880
| +188% | +$14.4K | ﹤0.01% | 5878 |
|
|
2020
Q3 | $5K | Sell |
1,000
-1,288
| -56% | -$6.44K | ﹤0.01% | 6474 |
|
|
2020
Q2 | $14K | Sell |
2,288
-10,426
| -82% | -$63.8K | ﹤0.01% | 5954 |
|
|
2020
Q1 | $56K | Sell |
12,714
-24,508
| -66% | -$108K | ﹤0.01% | 4868 |
|
|
2019
Q4 | $354K | Buy |
37,222
+27,261
| +274% | +$259K | ﹤0.01% | 4179 |
|
|
2019
Q3 | $78K | Buy |
+9,961
| New | +$78K | ﹤0.01% | 4990 |
|
|
2019
Q2 | – | Sell |
-23
| Closed | – | – | 7231 |
|
|
2019
Q1 | $0 | Buy |
+23
| New | – | ﹤0.01% | 7234 |
|
|
2018
Q4 | – | Sell |
-2,868
| Closed | -$69K | – | 7305 |
|
|
2018
Q3 | $69K | Buy |
+2,868
| New | +$69K | ﹤0.01% | 5024 |
|